This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Leading cancer research organizations to host international cancer immunotherapy conference

August 3rd, 2015

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept. 16-19, 2015.

Titled "Translating Science into Survival," the meeting will cover all areas of inquiry in cancer immunology and immunotherapy, including: immune regulation of T-cell responsiveness, genomic methods for identifying tumor antigens, the tumor microenvironment, T-cell therapies, checkpoint blockade, biomarkers, combinations, and the microbiome. More than 60 talks by acknowledged leaders in these areas will be given.

The full program is available here: http://www.aacr.org/Meetings/Pages/Program-Detail.aspx?EventItemID=54&ItemID=149.

Registration is complimentary for credentialed news media. Members of the media can register using this form: http://www.aacr.org/Documents/15Immuno_RegForm.pdf. Return completed forms to Lauren Riley via email at lauren.riley@aacr.org or via fax at 215-446-7291.

Public information officers at medical institutes and cancer centers can also register by contacting Lauren Riley at lauren.riley@aacr.org or 215-446-7155.

Those following on social media can join the conversation on Twitter at #cicon15.

Provided by American Association for Cancer Research

Citation: Leading cancer research organizations to host international cancer immunotherapy conference (2015, August 3) retrieved 24 April 2024 from https://sciencex.com/wire-news/200055523/leading-cancer-research-organizations-to-host-international-canc.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.